Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review
Tessa Kennedy-Martin,1 Kristina S Boye,2 Xiaomei Peng2 1Kennedy-Martin Health Outcomes Ltd, Brighton, UK; 2Global Health Outcomes, Eli Lilly and Company, Indianapolis, IN, USA Purpose: To explore published evidence on health care costs associated with adherence or persistence to antidiabetes medic...
Main Authors: | Kennedy-Martin T, Boye KS, Peng X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/cost-of-medication-adherence-and-persistence-in-type-2-diabetes-mellit-peer-reviewed-article-PPA |
Similar Items
-
Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
by: Chen M, et al.
Published: (2016-03-01) -
Medication adherence and persistence in type 2 diabetes mellitus: perspectives of patients, physicians and pharmacists on the Spanish health care system
by: Labrador Barba E, et al.
Published: (2017-04-01) -
Insulin adherence and persistence among Chinese patients with type 2 diabetes: a retrospective database analysis
by: He X, et al.
Published: (2017-02-01) -
Medication non-adherence as a cause of hospital admissions
by: N. Martínez López de Castro, et al.
Published: (2014-07-01) -
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis
by: A. Sicras-Mainar, et al.
Published: (2018-12-01)